mk 0591 has been researched along with Alzheimer Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, J; Giannopoulos, PF; Joshi, YB; Kirby, LG; Li, JG; Praticò, D; Sperow, M | 1 |
| Chu, J; Di Meco, A; Lauretti, E; Praticò, D | 1 |
| Chu, J; Praticò, D | 1 |
3 other study(ies) available for mk 0591 and Alzheimer Disease
| Article | Year |
|---|---|
5-lipoxygenase activating protein reduction ameliorates cognitive deficit, synaptic dysfunction, and neuropathology in a mouse model of Alzheimer's disease.
Topics: 5-Lipoxygenase-Activating Protein Inhibitors; 5-Lipoxygenase-Activating Proteins; Alzheimer Disease; Amyloid beta-Peptides; Animals; Disease Models, Animal; Female; Indoles; Male; Maze Learning; Mice; Mice, Knockout; Mice, Transgenic; Quinolines; Synapses; tau Proteins | 2013 |
FLAP pharmacological blockade modulates metabolism of endogenous tau in vivo .
Topics: 5-Lipoxygenase-Activating Protein Inhibitors; 5-Lipoxygenase-Activating Proteins; Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Disks Large Homolog 4 Protein; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Guanylate Kinases; Indoles; Membrane Proteins; Mice; Mice, Transgenic; Microtubule-Associated Proteins; Phosphorylation; Quinolines; tau Proteins | 2013 |
Involvement of 5-lipoxygenase activating protein in the amyloidotic phenotype of an Alzheimer's disease mouse model.
Topics: 5-Lipoxygenase-Activating Protein Inhibitors; 5-Lipoxygenase-Activating Proteins; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Arachidonate 5-Lipoxygenase; Cells, Cultured; Disease Models, Animal; Female; Humans; Indoles; Mice; Mice, Transgenic; Phenotype; Quinolines; Random Allocation; RNA, Messenger | 2012 |